Maravai LifeSciences
MRVI
#4461
Rank
S$3.33 B
Marketcap
S$9.04
Share price
-0.71%
Change (1 day)
170.05%
Change (1 year)

Operating Margin for Maravai LifeSciences (MRVI)

Operating Margin as of July 2026 (TTM): -92.22%

According to Maravai LifeSciences 's latest financial reports and stock price the company's current Operating Margin is -92.22%. At the end of 2025 the company had an Operating Margin of -126.50%.

Operating Margin history for Maravai LifeSciences from 2020 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-126.50%25.39%
2024-100.89%-147.19%
2023213.79%242.31%
202262.45%-5.95%
202166.41%130.94%
202028.76%-803.26%
2019-4.09%-69.31%
2018-13.32%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Organovo
ONVO
-1,726.38% 1,772.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-129.00% 39.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
39.35%-142.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-22.05%-76.09% Jersey

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.